News About: Pharm. Industry
Domestic pharmaceutical firms urged to advance into Chinese pharmaceutical market in detailed...
Domestic pharmaceutical firms urged to advance into Chinese pharmaceutical market in detailed market analyses
The Korean firms effective inroads to the Chinese pharmaceutical market should require a group of market...
Vitamin C drink taking over tonic drink markets.
So called "Drink" market led by tonic drink preparations since long time has been rapidly reshuffled by the recent new market entries of vitamin C drink and wild ginseng preparations.
The tonic drink market has...
Wyeth Korea to launch Enbrel at year-end
Wyeth Korea announced the Korea Food and Drug Administration has recently approved Enbrel (entanercept), TNF (tumor necrosis factor) inhibitor for the treatment of rheumatoid arthritis drug, as local trials last March...
Chong Kun Dang to introduce novel ulcerative colitis medication from US-based Salix Pharmaceuticals
Chong Kun Dang Pharmaceuticals said it recently signed with the U.S.-based Salix Pharmaceuticals (Dr. Lorin Johnson, a co-founder of Salix), a leading pharmaceutical firm in the sales/marketing of digestive drugs, an ...
Dong-A's DA-8159 wins KIPO's patent award
Dong-A Pharm said its novel pyrazolopyrimidine derivative (DA-8159), an impotence medication, recently won Chi Seok-yong Award in the third quarter of this year from the Korean Intellectual Property Office.
DA-8159...
KPMA stresses fair trade code in scientific seminars
The Korea Pharmaceutical Manufacturers Association has recently urged pharmaceutical companies to strictly abide by a fair trade code in supporting a variety of scientific seminars at home and abroad.
Citing that p...
Sales and product development staffs in difficult situations
Because of a protracted business slow in the pharmaceutical industry the job positions of high executive members and staffs responsible for the company sales and new product development were getting squeezed.
Most ...
Crestor to start first multinational trials "DISCOVERY" in Korea
Pharmaceutical business sources say that local DISCOVERY trials for AstraZeneca's lead product Crestor for the treatment of hyperlipidemia are now underway with the initiative of a Korean chief investigator, with an a...
MSD Korea launches V65 campaign for Vioxx in Korea
MSD Korea said it has initiated a V65 campaign towards local doctors and patients from last September as part of its efforts to promote is lead product Vioxx for the treatment of arthritis, adding that its earlier "Vo...
Janssen Korea to file application for new anticancer in early next yearJanssen Korea said it would file a new application for Velcade, proteasome inhibitor in early next year in line with its launching program.
The U.S. FDA announced on May 13 t... |
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
